078070 — Ubiquoss Holdings Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩199bn
- KR₩87bn
- KR₩172bn
- 95
- 78
- 17
- 74
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 161,059 | 181,374 | 198,002 | 193,620 | 230,205 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 12,609 | 12,170 | 11,597 | 18,369 | 13,867 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 194,546 | 218,559 | 246,053 | 262,051 | 292,340 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 34,185 | 23,577 | 26,369 | 26,382 | 23,883 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 295,097 | 317,957 | 352,383 | 364,915 | 391,505 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 34,280 | 35,568 | 38,624 | 33,698 | 35,593 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 94,756 | 110,049 | 127,247 | 133,406 | 149,489 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 200,341 | 207,907 | 225,136 | 231,509 | 242,015 |
Total Liabilities & Shareholders' Equity | 295,097 | 317,957 | 352,383 | 364,915 | 391,505 |
Total Common Shares Outstanding |